Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT) (NCT05355272)
Growth Hormone Replacement Therapy in Veterans With Gulf War Illness and Adult Growth Hormone Deficiency
🩺 Plain-English Summary (8th-Grade Level)
The goal of the GWIT Study is to assess whether growth hormone replacement therapy is a safe and effective treatment for veterans with Gulf War Illness (GWI) and adult growth hormone deficiency (AGHD). The main questions the study aims to answer are: 1. Is growth hormone effective at reducing fat in the trunk of the body and symptoms of GWI among veterans with GWI and growth hormone deficiency? 2. Do the results of the study suggest there is merit in pursuing a larger trial to examine the efficacy of growth hormone as a treatment for growth hormone deficiency among veterans with Gulf War Illness? To determine eligibility for the study, veterans will be asked to complete several assessments including questionnaires, blood tests, and a scan of the brain. Participants who qualify for the study will receive recombinant human growth hormone for 6-months. A body composition scan will be performed at Day1, Day 90, and Day 180 of the intervention. Questionnaires and cognitive tests will also be collected before and after the trial.
Who can join: Review the eligibility criteria below.
Location: Michael E. DeBakey VA Medical Center — Houston, Texas
Age range: 18 Years to 64 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Michael E. DeBakey VA Medical Center — Houston, Texas
- VA Puget Sound Healthcare System — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (206) 419-1261
Email: Lane.Witkowski@bcm.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gulf War Syndrome
- Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness — Birmingham, Alabama
- Coenzyme Q10 for Gulf War Illness: A Replication Study — La Jolla, California
- GWICTIC: NAC Mechanistic Study in Gulf War Veterans — Palo Alto, California
- Validating Gulf War Illness Blood Biomarkers — Palo Alto, California
- Cranial Electrotherapy Stimulation and Brain Imaging for Gulf War Syndrome — Atlanta, Georgia
Explore by condition: All Gulf War Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.